ACQUISITION OF PHARMACEUTICAL PROFILES EXPANDS EARLY-PHASE DRUG DEVELOPMENT SERVICE OFFERING

Date: 15/12/2008

Newmarket, United Kingdom, December 15, 2008 – Quotient Bioscience Group Limited ("Quotient"), a leading European provider of analytical and safety evaluation services and products for bioscience and sport, is pleased to announce that it has acquired Pharmaceutical Profiles Group Limited ("Pharmaceutical Profiles"). Pharmaceutical Profiles will become an important member of Quotient's Drug Development Services Group - Quotient Bioresearch.